Health Canada accepts marketing application for Mithra ’s hormone therapy Tibelia

Health Canada has accepted a marketing authorisation application for the Belgian pharmaceutical company Mithra ’s complex therapeutic Tibelia, a tibolone-based product, to be used in hormone therapy (HT).
Source: Pharmaceutical Technology - Category: Pharmaceuticals Source Type: news